Antibiotics for children with urinary tract infections create even more problems

NewsGuard 100/100 Score

New research has questioned the use of antibiotics for children with urinary tract infections.

The research suggests that giving children antibiotics to prevent the return of repeated urinary tract infections does not work and in fact only serves to encourage infections that are resistant to the drugs.

Experts say as many as 180,000 children in the U.S. will have had a urinary tract infection by the time they reach age 6 and preventive daily use of antimicrobials is often recommended in cases of repeated infections.

This is especially so where tests indicate they have a backflow of urine from the bladder into the ureter, which connects to the kidneys and this occurs in 40% of cases.

Dr. Patrick Conway formerly of the Children's Hospital of Philadelphia and his team found that daily antibiotic treatment did not decrease the risk of recurrent urinary tract infections and was in fact associated with an increased risk of resistant infections.

This in turn made the infection harder to treat.

Their research was based on the medical records of nearly 700 children over a period between July 2001 and May 2006 and the researchers concluded that doctors should discuss the risks and unclear benefits of antibiotics for recurring urinary tract infections, as exposure to antibiotics significantly increased the likelihood of resistant infections.

The study is published in the current issue of JAMA: The Journal of the American Medical Association.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vosoritide's first phase 2 study shows increased growth in children with hypochondroplasia